Neuropeptide Y

Generic Name
Neuropeptide Y
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
82785-45-3
Unique Ingredient Identifier
BY7U39XXK0
Background

Neuropeptide Y is under investigation for the basic science of Type 2 Diabetes Mellitus.

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Early Phase 1
Recruiting
Conditions
Hypertension
Obesity
Interventions
Drug: Neuropeptide Y
First Posted Date
2021-04-09
Last Posted Date
2024-08-12
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
100
Registration Number
NCT04838678
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder

First Posted Date
2019-08-28
Last Posted Date
2019-08-28
Lead Sponsor
New York Medical College
Target Recruit Count
117
Registration Number
NCT04071600
Locations
🇺🇸

Westchester Medical Center, Valhalla, New York, United States

🇺🇸

New York Medical College, Valhalla, New York, United States

Effect of DPP4 Inhibition on Vasoconstriction

First Posted Date
2015-12-24
Last Posted Date
2018-08-27
Lead Sponsor
Vanderbilt University
Target Recruit Count
18
Registration Number
NCT02639637
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)

Phase 1
Completed
Conditions
Posttraumatic Stress Disorder
Interventions
Drug: Neuropeptide Y
First Posted Date
2012-02-15
Last Posted Date
2016-04-14
Lead Sponsor
James Murrough
Target Recruit Count
26
Registration Number
NCT01533519
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy